Published

5-HT receptors: Pharmacology and functional selectivity.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmacological reviews
Date: 2025-07-01
Source: PubMed
DOI: 10.1016/j.pharmr.2025.100059
PubMed: 40418878

Authors

Cummins BR Billac GB Nichols DE Nichols CD

Watch author

Derived topics and classifications

psilocybin Depression Addiction Pharmacology Mechanism of Action Receptor Pharmacology Aging Clinical Trial Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders2025-11-13 5-HT receptors: Pharmacology and functional selectivity.2025-07-01

Related papers

Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-10-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07